houseboy -
The last I saw about
this was based on recent clinical trial data on overall survival among men who had used docetaxel, and were metastatic and castration resistant. It was about
median overall survival and not prostate cancer-specific survival. As you can see, median survival with lung mets was similar to survival with bone mets.
lymph node only mets - 31.6 mos.
bone or bone with LN (but no visceral) -21.3 mos.
any lung (but no liver) - 19.4 mos.
any liver - 13.5 mos.
jco.ascopubs.org/content/34/14/1652